Historique de carrière de Russell Wilson
Anciens postes connus de Russell Wilson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NOVAVAX, INC. | Chief Tech/Sci/R&D Officer | 15/11/2011 | 28/03/2012 |
| Corporate Officer/Principal | 01/11/2011 | 01/11/2023 | |
| IOMAI CORPORATION | Director of Finance/CFO | 01/03/2000 | 01/08/2008 |
| General Counsel | 01/03/2000 | 01/08/2008 | |
| Corporate Secretary | 01/03/2000 | 01/08/2008 | |
North American Vaccine, Inc.
 North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology North American Vaccine, Inc. develops and sells vaccines for the prevention of infectious diseases. The company is based in Columbia, MD. The company was founded by Jeffrey G. Spragens. North American Vaccine was acquired by Baxter International, Inc. on June 27, 2000 for $250.67 million. | General Counsel | - | 01/01/2000 |
| SUPERNUS PHARMACEUTICALS, INC. | Director of Finance/CFO | 11/06/2009 | - |
Formation de Russell Wilson
| University of Virginia | Graduate Degree |
| Princeton University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Director of Finance/CFO | 2 |
| General Counsel | 2 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NOVAVAX, INC. | Health Technology |
| SUPERNUS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
North American Vaccine, Inc.
North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology North American Vaccine, Inc. develops and sells vaccines for the prevention of infectious diseases. The company is based in Columbia, MD. The company was founded by Jeffrey G. Spragens. North American Vaccine was acquired by Baxter International, Inc. on June 27, 2000 for $250.67 million. | Health Technology |
Intercell USA, Inc.
 Intercell USA, Inc. BiotechnologyHealth Technology Intercell USA, Inc. discovers and develops vaccines and immune system stimulants. The vaccine patch enhances the efficacy of existing vaccines, enables new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. The company was founded by Gregory M. Glenn and Dean P. Lewis in September 1997 and is headquartered in Gaithersburg, MD. | Health Technology |
- Bourse
- Insiders
- Russell Wilson
- Expérience
